Category: Pharmaceuticals
Pharmaceuticals market research reports by GlobalData
-
Atopic Dermatitis (Atopic Eczema) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Atopic Dermatitis (Atopic Eczema) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Atopic Dermatitis (Atopic Eczema) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Spo ... Read More
-
Gall Stone Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Gall Stone Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Gall Stone Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provi ... Read More
-
TBG Diagnostics Ltd - Strategic SWOT Analysis Review
TBG Diagnostics Ltd - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ... Read More
-
Business of the Bundesliga 2023-24 - Property Profile, Sponsorship and Media Landscape
Business of the Bundesliga 2023-24 - Property Profile, Sponsorship and Media Landscape Summary A complete overview of the commercial landscape of the Bundesliga season. The report takes a closer look at the league from a social media, sponsorship and media perspective. It also takes a closer look at ... Read More
-
EU5 ICP Procedures Count and Forecast to 2030
EU5 ICP Procedures Count and Forecast to 2030 Summary GlobalData’s “EU5 ICP Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the EU5 ICP Procedures. The EU5 ICP Procedures report provides key information and data on - Procedure volume data for ICP Proce ... Read More
-
Asia-Pacific (APAC) ICP Procedures Count and Forecast to 2030
Asia-Pacific (APAC) ICP Procedures Count and Forecast to 2030 Summary GlobalData’s “Asia-Pacific ICP Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Asia-Pacific ICP Procedures. The Asia-Pacific ICP Procedures report provides key information and da ... Read More
-
BRIC ICP Procedures Count and Forecast to 2030
BRIC ICP Procedures Count and Forecast to 2030 Summary GlobalData’s “BRIC ICP Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the BRIC ICP Procedures. The BRIC ICP Procedures report provides key information and data on - Procedure volume data for ICP P ... Read More
-
North America ICP Procedures Count and Forecast to 2030
North America ICP Procedures Count and Forecast to 2030 Summary GlobalData’s “North America ICP Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the North America ICP Procedures. The North America ICP Procedures report provides key information and data ... Read More
-
United Kingdom (UK) Health and Beauty Market Size, Trends, Consumer Attitudes and Key Players to 2027
United Kingdom (UK) Health and Beauty Market Size, Trends, Consumer Attitudes and Key Players to 2027 Summary The UK Health & Beauty report offers a comprehensive insight into the Health & Beauty market in the UK, analysing the sector, the major players, the main trends, and consumer attitudes, as w ... Read More
-
Almirall - Digital Transformation Strategies
Almirall - Digital Transformation Strategies Summary This report provides insights into Almirall’s tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives. Almirall is a global biopharmaceutical company specializing in dermatology. Th ... Read More
-
Allergan Ltd - Strategic SWOT Analysis Review
Allergan Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. ... Read More
-
AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review
AcelRx Pharmaceuticals Inc (ACRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we ... Read More
-
Johnson & Johnson - Digital Transformation Strategies
Johnson & Johnson - Digital Transformation Strategies Summary Johnson & Johnson (J&J) and its subsidiary companies are engaged in the research & development, production and sale of a variety of human healthcare and wellbeing products. The company operates through three business segments: Consumer He ... Read More
-
Guided Health - Consumer TrendSights Analysis, 2023
Guided Health - Consumer TrendSights Analysis, 2023 Summary Guided Health is one of the 63 sub-trends that GlobalData covers as part of our TrendSights series of Consumer Insight studies. The analysis covers what the trend is, why it is important, who is most influenced by it and how brands and manu ... Read More
-
Idiopathic Hypersomnia (IH) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Idiopathic Hypersomnia (IH) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in IH therapeutics. More than 280,000 diagnosed prevalent cases of IH are anticipated in ... Read More
-
Diabetic Nephropathy (DN) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Diabetic Nephropathy (DN) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in DN therapeutics. More than 16 million diagnosed prevalent cases of DN are anticipated in ... Read More
-
Yiaco Medical Co (YIACO) - Financial and Strategic SWOT Analysis Review
Yiaco Medical Co (YIACO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses ... Read More
-
IgA Nephropathy (Berger's Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
IgA Nephropathy (Berger's Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Berger's Disease therapeutics. More than 100,000 incident cases of Berger’s Dis ... Read More
-
United Kingdom (UK) Minimally Invasive Neurosurgery Procedures Count and Forecast to 2030
United Kingdom (UK) Minimally Invasive Neurosurgery Procedures Count and Forecast to 2030 Summary GlobalData’s “United Kingdom Minimally Invasive Neurosurgery Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the United Kingdom Minimally Invasive Neurosu ... Read More
-
Social Anxiety Disorder (SAD/Social Phobia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Social Anxiety Disorder (SAD/Social Phobia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Social Anxiety Disorder (SAD/Social Phobia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End ... Read More
-
Arthralgia (Joint Pain) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Arthralgia (Joint Pain) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Arthralgia (Joint Pain) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top C ... Read More
-
Autism Spectrum Disorder (ASD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Autism Spectrum Disorder (ASD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Autism Spectrum Disorder (ASD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor T ... Read More
-
Reflux Esophagitis (Gastroesophageal Reflux Disease) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Reflux Esophagitis (Gastroesophageal Reflux Disease) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Reflux Esophagitis (Gastroesophageal Reflux Disease) Clinical Trial Analysis by Trial Phase, Trial Status, ... Read More
-
Sanofi S.A - Digital Transformation Strategies
Sanofi S.A - Digital Transformation Strategies Summary This report provides insight into Sanofi's digital technology activities, including its digital transformation strategies, its accelerators, incubators, and other innovation programs, its technology initiatives, venture arm, investments, and its ... Read More
-
Hypocobalaminemia (Vitamin B12) Deficiency Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Hypocobalaminemia (Vitamin B12) Deficiency Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Hypocobalaminemia (Vitamin B12) Deficiency Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End P ... Read More
Research Assistance
